Article Information
History
- January 18, 2022.
Article Versions
- Version 1 (November 11, 2021 - 10:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ayorinde O. Afolayan1,
- Aaron O. Aboderin2,
- Anderson O. Oaikhena1,
- Erkison Ewomazino Odih1,
- Veronica O. Ogunleye3,
- Adeyemi T. Adeyemo4,
- Abolaji T. Adeyemo5,
- Oyeniyi S. Bejide1,
- Anthony Underwood6,
- Silvia Argimón6,
- Monica Abrudan6,
- Abiodun Egwuenu7,
- Chikwe Ihekweazu7,
- David M. Aanensen6 and
- Iruka N. Okeke1,*
- 1Global Health Research Unit for the Genomic Surveillance of Antimicrobial Resistance, Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Oyo State, Nigeria
- 2Department of Medical Microbiology and Parasitology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria
- 3Department of Medical Microbiology and Parasitology, University College Hospital, Ibadan, Oyo State, Nigeria
- 4Department of Medical Microbiology and Parasitology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria
- 5Department of Medical Microbiology and Parasitology, University of Osun Teaching Hospital, Osogbo, Osun State, Nigeria
- 6Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Old Road Campus, Oxford, United Kingdom and Wellcome Genome Campus, Hinxton, UK
- 7Nigeria Centre for Disease Control, Jabi, Abuja, Nigeria
- ↵*Corresponding author:
Iruka N. Okeke. Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Oyo State, Nigeria. +234 805 328 1714. iruka.n.okeke{at}gmail.com